Full Text
Budget Impact Analysis of Bevacizumab and Anti-Egfr with Chemotherapy for First and Second Line Treatment of Metastatic Colorectal Cancer in Russian Federation

Abstract

Authors

R. Yagudina A. Kulikov I. Komarov

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×